Department of Preventive Medicine and Microbiology, Universidad Autonoma de Madrid, Calle Arzobispo Morcillo, 4, 28029, Madrid, Spain; Department of Preventive Medicine, Hospital Severo Ochoa, Avenida de Orellana, 28914, Madrid, Spain; Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Carlos III Health Institute, Calle de Melchor Fernández Almagro, 5, 28029, Madrid, Spain.
Department of Preventive Medicine and Microbiology, Universidad Autonoma de Madrid, Calle Arzobispo Morcillo, 4, 28029, Madrid, Spain; Area of Renal Risk and Cardiometabolic Disease, Instituto de Investigación Sanitaria Hospital Clinic de Valencia (INCLIVA), Avinguda de Menéndez y Pelayo, 4, 46010, Valencia, Spain; Department of Statistics and Operational Research, University of Valencia, Calle Dr. Moliner, 50, 46100, Valencia, Spain.
Free Radic Biol Med. 2021 Jan;162:392-400. doi: 10.1016/j.freeradbiomed.2020.10.318. Epub 2020 Oct 31.
Experimental data suggest that trace elements, such as arsenic (As), cadmium (Cd), and selenium (Se) can influence the bone remodeling process. We evaluated the cross-sectional association between As, Cd, and Se biomarkers with bone mineral density (BMD) measured at the calcaneus, in a representative sample of a general population from Spain. As secondary analyses we evaluated the associations of interest in subgroups defined by well-established BMD determinants, and also conducted prospective analysis of osteoporosis-related incident bone fractures restricted to participants older than 50 years-old.
In N = 1365 Hortega Study participants >20 years-old, urine As and Cd were measured by inductively coupled-plasma mass spectrometry (ICPMS); plasma Se was measured by atomic absorption spectrometry (AAS) with graphite furnace; and BMD at the calcaneus was measured using the Peripheral Instaneuous X-ray Imaging system (PIXI). As levels were corrected for arsenobetaine (Asb) to account for inorganic As exposure.
The median of total urine As, Asb-corrected urine As, urine Cd, and plasma Se was 61.3, 6.53 and 0.39 μg/g creatinine, and 84.9 μg/L, respectively. In cross-sectional analysis, urine As and Cd were not associated with reduced BMD (T-score < -1 SD). We observed a non-linear dose-response of Se and reduced BMD, showing an inverse association below ~105 μg/L, which became increasingly positive above ~105 μg/L. The evaluated subgroups did not show differential associations. In prospective analysis, while we also observed a U-shape dose-response of Se with the incidence of osteoporosis-related bone fractures, the positive association above ~105 μg/L was markedly stronger, compared to the cross-sectional analysis.
Our results support that Se, but not As and Cd, was associated to BMD-related disease. The association of Se and BMD-related disease was non-linear, including a strong positive association with osteoporosis-related bone fractures risk at the higher Se exposure range. Considering the substantial burden of bone loss in elderly populations, additional large prospective studies are needed to confirm the relevance of our findings to bone loss prevention in the population depending on Se exposure levels.
实验数据表明,微量元素如砷(As)、镉(Cd)和硒(Se)可以影响骨重塑过程。我们评估了西班牙代表性一般人群样本中,痕量元素生物标志物砷(As)、镉(Cd)和硒(Se)与跟骨骨密度(BMD)之间的横断面关联。作为次要分析,我们评估了在既定 BMD 决定因素定义的亚组中感兴趣的关联,并且还对仅限于 50 岁以上参与者的与骨质疏松症相关的骨骨折进行了前瞻性分析。
在 N=1365 名 Hortega 研究的 20 岁以上参与者中,使用电感耦合等离子体质谱法(ICPMS)测量尿液中的 As 和 Cd;使用石墨炉原子吸收光谱法(AAS)测量血浆中的 Se;并使用外周瞬时 X 射线成像系统(PIXI)测量跟骨的 BMD。As 水平经过砷甜菜碱(Asb)校正,以反映无机 As 的暴露情况。
尿液总 As、Asb 校正尿液 As、尿液 Cd 和血浆 Se 的中位数分别为 61.3、6.53 和 0.39μg/g 肌酐,以及 84.9μg/L。在横断面分析中,尿液 As 和 Cd 与降低的 BMD(T 评分< -1 SD)无关。我们观察到 Se 与降低的 BMD 之间存在非线性剂量反应关系,在低于约 105μg/L 时呈反比关系,在高于约 105μg/L 时呈正相关关系。评估的亚组没有显示出不同的关联。在前瞻性分析中,尽管我们还观察到 Se 与骨质疏松症相关骨折的发生率呈 U 形剂量反应关系,但与横断面分析相比,在较高的 Se 暴露范围内,阳性关联要强得多。
我们的结果支持 Se 与 BMD 相关疾病有关,而不是 As 和 Cd。Se 与 BMD 相关疾病的关联是非线性的,包括与骨质疏松症相关的骨折风险呈强正相关,尤其是在较高的 Se 暴露范围内。考虑到老年人群中骨丢失的负担很大,需要进行更多的大型前瞻性研究来证实我们的发现对人群中依赖 Se 暴露水平的骨丢失预防的相关性。